Georg Plassmann

Affiliations

UHZ Klinische Forschung, Essen, Germany.

Réseau de co-auteurs

Frank-Peter Tillmann 1 collaboration

Lars Figiel 1 collaboration

Johannes Ricken 1 collaboration

Hermann Still 1 collaboration

Christoph Korte 1 collaboration

Grete Plassmann 1 collaboration

Philipp von Landenberg 1 collaboration

Céline Boutry 1 collaboration

Andrew Hastie 1 collaboration

Javier Diez-Domingo 1 collaboration

Juan Carlos Tinoco 1 collaboration

Chong-Jen Yu 1 collaboration

Charles Andrews 1 collaboration

Jean Beytout 1 collaboration

Covadonga Caso 1 collaboration

Huey-Shinn Cheng 1 collaboration

Hee Jin Cheong 1 collaboration

Eun Ju Choo 1 collaboration

Dan Curiac 1 collaboration

Emmanuel Di Paolo 1 collaboration

Marc Dionne 1 collaboration

Tamara Eckermann 1 collaboration

Meral Esen 1 collaboration

Murdo Ferguson 1 collaboration

Wayne Ghesquiere 1 collaboration

Shinn-Jang Hwang 1 collaboration

Thiago Junqueira Avelino-Silva 1 collaboration

Pavel Kosina 1 collaboration

Chiu-Shong Liu 1 collaboration

Jukka Markkula 1 collaboration

Beate Moeckesch 1 collaboration

Cláudia Murta de Oliveira 1 collaboration

Dae Won Park 1 collaboration

Karlis Pauksens 1 collaboration

Paola Pirrotta 1 collaboration

Carol Pretswell 1 collaboration

Lars Rombo 1 collaboration

Bruno Salaun 1 collaboration

Johan Sanmartin Berglund 1 collaboration

Isabelle Schenkenberger 1 collaboration

Tino Schwarz 1 collaboration

Meng Shi 1 collaboration

Benita Ukkonen 1 collaboration

Toufik Zahaf 1 collaboration

Cristiano Zerbini 1 collaboration

Anne Schuind 1 collaboration

Anthony L Cunningham 1 collaboration

None None 1 collaboration

Georg Plassmann

Affiliations

Publications (2)

Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study.

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.

Réseau de co-auteurs